CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Different Types of Clinical Trial Recruitment Strategies

Different Types of Clinical Trial...

Clinically Media's Ceo Named One Of The Most Influential People In Healthcare Today

Clinically Media's Ceo Named One Of...

How to Use Clinical Trial Matching Software for The Trials?

How to Use Clinical Trial Matching...

Advanced HPV-16 Positive Head and Neck Cancer: PDS Biotech Enlists First Stage of Checkpoint Inhibitor Nave Patients

Advanced HPV-16 Positive Head and...

StudyKIK Acquired by Syneos Health to Deliver Patient and Physician Benefits

StudyKIK Acquired by Syneos Health to...

Syneos Health Partners with Ride Health

Syneos Health Partners with Ride Health

How Patient Recruitment Technologies Can Enhance Clinical Trials

How Patient Recruitment Technologies...

Patient Recruitment: Market and Strategies

Patient Recruitment: Market and...

Different Types of Clinical Trial Recruitment Strategies

Different Types of Clinical Trial...

Clinically Media's Ceo Named One Of The Most Influential People In Healthcare Today

Clinically Media's Ceo Named One Of...

How to Use Clinical Trial Matching Software for The Trials?

How to Use Clinical Trial Matching...

Advanced HPV-16 Positive Head and Neck Cancer: PDS Biotech Enlists First Stage of Checkpoint Inhibitor Nave Patients

Advanced HPV-16 Positive Head and...

StudyKIK Acquired by Syneos Health to Deliver Patient and Physician Benefits

StudyKIK Acquired by Syneos Health to...

Syneos Health Partners with Ride Health

Syneos Health Partners with Ride Health

How Patient Recruitment Technologies Can Enhance Clinical Trials

How Patient Recruitment Technologies...

Patient Recruitment: Market and Strategies

Patient Recruitment: Market and...

Role of Decentralized Clinical Trials in Patient Recruitment

Life Sciences Review | Wednesday, May 11, 2022
Tweet

Decentralized trial technology can enable clinics that are not used to research. Patients’ current caregivers will be able to manage their study, increasing trust and keeping clinic visits close to home.


FREMONT, CA: Patients and clinical trial staff can communicate data remotely in Decentralized Clinical Trials (DCTs), effectively lowering the number of time patients spend at the study site and the number of in-person visits sponsors monitors must make to sites. Patients can visit local community health services and pharmacies instead of the research site, and sponsor monitors can access relevant papers online.


DCTs produce ‘localized trials,’ in which the study’s researchers can use local pharmacies, primary care doctors, and community health centers as extensions of prominent research institutes. Meeting individuals where they are makes it easier to recruit trial participants who match the study’s eligibility requirements.


According to a recent analysis, recruiting people is one of the most challenging tasks of a clinical trial. About half of clinical trials need to prolong their recruiting timeframes, and 37 percent of locations fail to reach their enrollment goals entirely. These recruitment delays can cost anywhere from 600,000 to 8 million dollars each day in potential income.


DCTs can help with this problem in two ways: they make it easier to discover eligible patients and encourage those patients to participate by lowering their travel time. According to a recent study, more than 70 percent of the population lives more than two hours distant from a research site.


Expanding Patient Diversity


How does one ensure that underrepresented patient populations are included in a trial while dealing with patient recruitment? There are two ways patient diversity can be directly impacted by DCTs, in addition to other strategies such as broadening eligibility criteria, partnering with community-based medical centers, and using patient advocacy groups.


Create New Trial Sites in New Communities: Decentralized trial technology can enable clinics that are not used to research. Patients’ current caregivers will be able to manage their study, increasing trust and keeping clinic visits close to home. Patients who are apprehensive about visiting a large medical center can easily enroll.


Create Trial Sites Around the Patients: The old, centralized approach to study management was based on constructing a trial site and then recruiting patients to it. A ‘site’ can now be constructed between one patient and one practitioner, and in certain circumstances, the site is only the patient’s phone.


Finally, decentralization enables hyper-local trials, allowing research to move away from large medical centers and places where varied individuals feel most at ease and are thus more likely to participate. However, decentralized technology is only one element of the equation when it comes to increasing patient diversity.


See Also: Top 10 Business Continuity Consulting/Services Companies


Weekly Brief

loading
Top 10 Patient Recruitment Solutions Companies - 2022
> <
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue

Read Also

Qualities to Consider when Choosing Life Sciences Business Consultants for Your Firm

How Biotech Startups can Mitigate Risks in Order to Grow Sustainably

Cellf BIO's BioShincter to Undergo Phase 1 Trail to Test Fecal Incontinence Treatment

Fulcrum Therapeutics Announces CEO Transition

An Overview of Wholesalers' Roles in Complex Supply Chains

Veeva Opening Up Integration Module for Future Opportunities and Applications

Veeva Systems To Accelerate the CRM of Life Science Businesses

The Role of Technology in Advancing Clinical Trials

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/role-of-decentralized-clinical-trials-in-patient-recruitment--nwid-460.html